Baseline Magnetic Resonance Imaging Parameters and Stroke Outcome in Patients Treated by Intravenous Tissue Plasminogen Activator
- 1 February 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 34 (2), 458-463
- https://doi.org/10.1161/01.str.0000053850.64877.af
Abstract
Background and Purpose— We designed a prospective sequential pretreatment and posttreatment MRI study to assess the relation between neuroimaging parameters and clinical outcome in patients treated...Keywords
This publication has 19 references indexed in Scilit:
- Apparent Diffusion Coefficient Decreases and Magnetic Resonance Imaging Perfusion Parameters are Associated in Ischemic Tissue of Acute Stroke PatientsJournal of Cerebral Blood Flow & Metabolism, 2001
- Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemiaAnnals of Neurology, 2001
- Combined Perfusion- and Diffusion-weighted MR Imaging in Acute Ischemic Stroke during the 1st Week: A Longitudinal StudyRadiology, 2000
- Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRIThe Lancet, 1999
- Evaluation of early reperfusion and IV tPA therapy using diffusion- and perfusion-weighted MRINeurology, 1999
- Hyperacute Stroke: Simultaneous Measurement of Relative Cerebral Blood Volume, Relative Cerebral Blood Flow, and Mean Tissue Transit TimeRadiology, 1999
- Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging.Radiology, 1996
- Clinical Outcome in Ischemic Stroke Predicted by Early Diffusion-Weighted and Perfusion Magnetic Resonance Imaging: A Preliminary AnalysisJournal of Cerebral Blood Flow & Metabolism, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993